Because reverse engineering allows you test and develop products at negligible cost compared with novel R+D.
Eventually (long after EDE has gone broke) CNT will be cheap enough to use as an admixture for certain applications. So it is sound practice to have developed and field tested a product in anticipation.
- Forums
- ASX - By Stock
- EDE
- Ann: Non Renounceable Rights Issue Prospectus
Ann: Non Renounceable Rights Issue Prospectus, page-23
-
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.427M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $20 | 10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
71 | 193077450 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 8333137 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
71 | 193077450 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 8333137 | 11 |
0.003 | 45152691 | 28 |
0.004 | 8674367 | 6 |
0.007 | 50000 | 1 |
0.008 | 678361 | 1 |
Last trade - 14.17pm 24/07/2024 (20 minute delay) ? |
Featured News
EDE (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online